Skip to main content

Month: March 2020

New Look Vision Group Inc. Reports Record Results for the Fourth Quarter and Year End Fiscal 2019 and Provides Actions in Response to COVID-19

MONTREAL, March 19, 2020 (GLOBE NEWSWIRE) — New Look Vision Group Inc. (“New Look Vision” or the “Company”) (TSX: BCI), a leader in the Canadian retail optical industry with 394 stores across Canada and Florida, reported financial results today for the 13 and 52 week periods ended December 28, 2019 (“Q4 2019”). This press release should be read in conjunction with the Company’s management discussion and analysis (the “MD&A”) and consolidated financial statements for fiscal 2019, which are available on the Company’s website at www.newlookvision.ca/investors and have been posted on SEDAR at www.sedar.com.Q4 2019 Financial and Operational HighlightsRevenues increased by 3.9% over last year to reach a record $73.9 million.Comparable store sales orders(a) were up by 3.6% compared to the fourth quarter...

Continue reading

Groupe Vision New Look Inc. annonce des résultats records pour le quatrième trimestre et l’exercice de 2019 et réagit à la COVID-19

MONTRÉAL, 19 mars 2020 (GLOBE NEWSWIRE) — Groupe Vision New Look Inc. (« Vision New Look » ou la « société ») (TSX: BCI), un chef de file dans la vente au détail dans l’industrie de l’optique au Canada avec ses 394 magasins au Canada et en Floride, a annoncé aujourd’hui ses résultats financiers pour les périodes de 13 et 52 semaines terminées le 28 décembre 2019. Ce communiqué devrait être lu à la lumière du rapport de gestion et des états financiers consolidés  pour l’exercice 2019, lesquels sont disponibles sur le site de la société à www.newlookvision.ca/Investisseurs et aussi sur SEDAR à www.sedar.com.Faits saillants financiers et d’exploitation du quatrième trimestre de 2019Le chiffre d’affaires a augmenté de 3,9 % par rapport à l’année dernière pour atteindre le montant record de  73,9 millions $.Les commandes de ventes des...

Continue reading

FALCO INCREASES OFFER FOR GOLDEN QUEEN MINING CONSOLIDATED LTD.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTRÉAL, March 19, 2020 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX-V: FPC) (“Falco” or the “Corporation“) announces today that, in connection with the proposed plan of arrangement (the “Arrangement“) with Golden Queen Mining Consolidated Ltd. (“Golden Queen“), announced on February 11, 2020, Falco decided to increase the consideration offered to the shareholders of Golden Queen (“Golden Queen Shareholders“). Golden Queen’s sole asset is a cash balance estimated at approximately $4.2 million at closing of the transaction.As a consequence of recent extraordinary events, global market conditions and decline in its share price, Falco increases its initial offer to Golden Queen...

Continue reading

FALCO BONIFIE SON OFFRE POUR GOLDEN QUEEN MINING CONSOLIDATED LTD.

NE PAS DISTRIBUER AUX AGENCES DE TRANSMISSION DES ÉTATS‑UNIS NI DIFFUSER AUX ÉTATS‑UNISMONTRÉAL, 19 mars 2020 (GLOBE NEWSWIRE) — Ressources Falco Ltée (TSX‑V : FPC) (« Falco » ou la « Société ») annonce aujourd’hui que, dans le cadre du plan d’arrangement proposé (l’« arrangement ») avec Golden Queen Mining Consolidated Ltd. (« Golden Queen »), annoncé le 11 février 2020, Falco a décidé de bonifier la contrepartie offerte aux actionnaires de Golden Queen (les « actionnaires de Golden Queen »). Le seul actif de Golden Queen est un solde de trésorerie estimé à environ 4,2 millions de dollars à la clôture de la transaction.Compte tenu d’événements récents extraordinaires, de la conjoncture du marché mondial et de la diminution de la valeur de l’action de Falco, Falco bonifie son offre initiale aux actionnaires de Golden Queen et propose...

Continue reading

GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test

COVID-19 diagnosis in under two hours now available globally in hospitals on company’s ePlex SystemUnique sample-to-answer capability enables near patient testing for the most critical patient populationsCARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) —  GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the company’s ePlex SARS-CoV-2 Test.GenMark’s test was developed for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples for patients suspected of COVID-19 by their health care provider. Rapid and easy detection of SARS-CoV-2 is becoming increasingly critical and customers are adopting the ePlex test based on the workflow...

Continue reading

Pixelworks 技术为HMD Global新推出的5G智能手机—诺基亚8.3提供PureDisplay功能,实现沉浸式5G内容

加利福尼亚州圣何塞, March 20, 2020 (GLOBE NEWSWIRE) — Pixelworks, Inc.(纳斯达克股票代码:PXLW),一家业界领先提供低功耗视频处理解决方案的企业今日宣布,具备PureDisplay观看体验的5G智能手机诺基亚8.3采用了Pixelworks视觉处理器。作为HMD Global推出的首款5G智能手机,诺基亚8.3为消费者带来了影院级大屏幕技术,并在一款高性价比的高端智能手机上提供了非凡的移动娱乐体验。该手机在所有照明环境中都具有清晰逼真的显示效果,让消费者能沉浸在随时可得的视频和交互式游戏中,这些内容通过超高速的5G网络变得更加普及。搭载高通®骁龙™765G模块平台的诺基亚8.3手机,拥有迄今为止诺基亚智能手机上最大的PureDisplay显示屏。这款6.81英寸无边框屏幕采用了由Pixelworks视觉处理器支持的PureDisplay技术,该技术包括了以下这些高级功能:全时HDR –以多达十亿种色彩的沉浸细节准确地显示HDR视频,并将所有其他内容实时转换为HDR体验,以提供全时的电影体验。 增强图像质量–凭借出色的色彩准确性、清晰度和局部对比度,诺基亚8.3智能手机的屏幕能以生动准确的色彩显示影像,同时在黑暗区域和明亮的光线下均可显示隐藏的细节且不过度曝光图像的其他部分。自适应显示–在保持图像质量的同时用动态调节来补偿环境光线,从昏暗的房间到阳光明媚的户外,在所有观看条件下都可轻松观看,始终保持出色的清晰度。 绝对的色彩精度–借助 Pixelworks的高效显示校准功能,消费者可以重现色彩生动逼真的照片和视频所捕捉的瞬间,享受色彩匹配准确的无忧在线购物,以及逼真的游戏体验。即使内容只是标准动态范围(SDR)格式,Pixelworks处理器仍可为所有流媒体、视频或游戏提供逼真的色彩再现和沉浸式全时HDR质量。这是通过将色彩深度和细节动态提升64倍来实现的,将所有的娱乐内容变成难忘的视觉体验。HMD全球首席产品官Juho...

Continue reading

Purpose Investments Inc. Announces March Distributions

TORONTO, March 19, 2020 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the following distributions for the month of March 2020. The ex-distribution date for all ETFs is March 26, 2020, with the exception of Purpose High Interest Savings ETF and Purpose US Cash ETF, which have an ex-distribution date of March 30, 2020. The ex-distribution date for all closed-end funds is March 30, 2020.(1) Dividend is designated as an “eligible” Canadian dividend for purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation.(2) Purpose US Preferred Share Fund Non-Currency Hedged – ETF Units have both a CAD and USD purchase option. Distribution per unit is declared in CAD, however, the USD purchase option (RPU.U) distribution will be made in the USD equivalent. Conversion into USD will use the...

Continue reading

SYSCO TO DONATE 2.5 MILLION MEALS OVER NEXT FOUR WEEKS

HOUSTON, March 19, 2020 (GLOBE NEWSWIRE) — Today, Sysco announced it will donate 2.5 million meals over the next four weeks as part of its community response strategy to the COVID-19 pandemic.The Company is closely collaborating with an array of critical stakeholders, from suppliers, customers, government entities and the non-profit sector, to address food insecurity and the added constraints on the food bank system during these challenging times.Sysco’s response strategy is focused on working with its key national partners, Feeding America in the U.S. and Second Harvest in Canada, in support of food redistribution efforts across the supply chain in North America. The strategy has a four-pronged approach focused around product donations, delivery to foodbanks, providing additional storage and supporting development of a mobile distribution...

Continue reading

Immutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti

Last patient enrolled and safely dosed, completing patient recruitment for EOC Pharma’s phase I study in metastatic breast cancer (MBC)Data expected throughout 2020, with study completion in Q4 CY2020Registration trial in MBC in China is plannedSYDNEY, Australia, March 19, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to report that it has been informed its Chinese partner, EOC Pharma, has completed patient recruitment for the ongoing EOC202A1101 study being conducted in China. EOC Pharma is an oncology focused specialty pharmaceutical company headquartered in Shanghai, China, and is the exclusive licensee of eftilagimod alpha (“efti” or “IMP321”) from Immutep for the Chinese market. The last patient was enrolled and safely dosed in February 2020, bringing the total...

Continue reading

Swiss Water Reports Strong 2019 Fourth Quarter and Annual Results

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — A conference call to discuss Swiss Water’s recent financial results will be held tomorrow, March 20th 2020 at 9:00 am Pacific Time (12:00 pm Eastern Time). To access the conference call, please dial (844) 602-0380 (toll free) or (862) 298-0970 (international). A replay will be available through April 03, 2020 at (919) 882-2331 (toll free) or (877) 481-4010 (international) passcode: 33625.Swiss Water Decaffeinated Coffee Inc. (TSX – SWP) (“Swiss Water” or “the company”) today reported strong financial results for the fourth quarter and year ended December 31, 2019. With annual processing volumes up by 16%, and gross profit up 11% year-over-year, the company’s strong growth trajectory continued unabated in 2019. Swiss Water is a premium green coffee decaffeinator that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.